Robert Mark Guinn

Title: The Innovations of Robert Mark Guinn

Introduction

Robert Mark Guinn is a notable inventor based in Mystic, Connecticut. He has made significant contributions to the field of chemistry, particularly in the development of processes for producing pharmaceutical compounds. With a total of two patents to his name, Guinn's work has had a meaningful impact on the industry.

Latest Patents

Guinn's latest patents include a process for the production of enantiomerically pure or optically enriched sertraline-tetralone using continuous chromatography. This innovative method involves a liquid mobile phase comprising at least one polar solvent and a solid chiral stationary phase made from a derivatized polysaccharide. His second patent, titled "Alatrofloxacin parenteral compositions," relates to alatrofloxacin mesylate that is substantially free of less polar impurities. This patent also covers parenteral compositions of alatrofloxacin mesylate and processes for purifying it.

Career Highlights

Throughout his career, Guinn has worked with prominent companies such as Pfizer Corporation and Chiral Technologies Europe. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in pharmaceutical chemistry.

Collaborations

Some of Guinn's notable coworkers include Subramanian Sam Guhan and John F Lambert. Their collaborative efforts have likely played a role in the successful development of his patented processes.

Conclusion

Robert Mark Guinn's contributions to the field of chemistry through his innovative patents demonstrate his expertise and commitment to advancing pharmaceutical science. His work continues to influence the industry and pave the way for future developments.